Insider Transactions in Q1 2023 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2023
|
Michael J Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+1.1%
|
-
|
Mar 31
2023
|
Arthur J Klausner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+9.82%
|
-
|
Mar 31
2023
|
Christopher M Starr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+12.18%
|
-
|
Mar 31
2023
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,154
-3.73%
|
$1,154
$1.39 P/Share
|
Mar 31
2023
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,063
+11.6%
|
-
|
Mar 31
2023
|
Kim R Tsuchimoto Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,842
-7.81%
|
$1,842
$1.39 P/Share
|
Mar 31
2023
|
Kim R Tsuchimoto Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,067
+17.69%
|
-
|
Mar 31
2023
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,286
-4.73%
|
$4,286
$1.39 P/Share
|
Mar 31
2023
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,911
+13.31%
|
-
|
Mar 31
2023
|
Raymond Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+11.62%
|
-
|
Jan 01
2023
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,327
-2.94%
|
$4,654
$2.37 P/Share
|
Jan 01
2023
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,723
+7.84%
|
-
|
Jan 01
2023
|
Kim R Tsuchimoto Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
502
-2.64%
|
$1,004
$2.37 P/Share
|
Jan 01
2023
|
Kim R Tsuchimoto Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,230
+6.08%
|
-
|